Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control.
Genes (Basel)
; 11(4)2020 04 23.
Article
en En
| MEDLINE
| ID: mdl-32340130
ABSTRACT
Gene doping, an activity which abuses and misuses gene therapy, is a major concern in sports and horseracing industries. Effective methods capable of detecting and monitoring gene doping are urgently needed. Although several PCR-based methods that detect transgenes have been developed, many of them focus only on a single transgene. However, numerous genes associated with athletic ability may be potential gene-doping material. Here, we developed a detection method that targets multiple transgenes. We targeted 12 genes that may be associated with athletic performance and designed two TaqMan probe/primer sets for each one. A panel of 24 assays was prepared and detected via a microfluidic quantitative PCR (MFQPCR) system using integrated fluidic circuits (IFCs). The limit of detection of the panel was 6.25 copy/µL. Amplification-specificity was validated using several concentrations of reference materials and animal genomic DNA, leading to specific detection. In addition, target-specific detection was successfully achieved in a horse administered 20 mg of the EPO transgene via MFQPCR. Therefore, MFQPCR may be considered a suitable method for multiple-target detection in gene-doping control. To our knowledge, this is the first application of microfluidic qPCR (MFQPCR) for gene-doping control in horseracing.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Eritropoyetina
/
Transgenes
/
Microfluídica
/
Doping en los Deportes
/
Reacción en Cadena en Tiempo Real de la Polimerasa
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Genes (Basel)
Año:
2020
Tipo del documento:
Article